Company: CBLO
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001882781-25-000034
Chunk: 19

Company: C2 Blockchain, Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 19
---
.00 for QC’s legal fees, resulting in net proceeds to the Company of $47,000.00.

The
QC Note matures on or about April 22, 2026 (nine months after the issue date) and is convertible at QC’s option into shares of
the Company’s common stock at a conversion price selected by QC, which may be either:

-A
fixed conversion price of $0.01, or 

-65%
of the lowest trading price of the Company’s common stock during the 20 trading days prior to conversion (the “Variable Conversion
Price”).

The
Company shall include on any registration and/or offering statement subsequently filed with the SEC, including without limitation any
offering statement on Form 1-A, all Conversion Shares and all Warrant Shares for resale by Quick Capital, LLC (the “Buyer”).
In addition to all other remedies available at law, in equity, or under this Agreement or any other Transaction Documents, failure to
comply with this obligation shall result in liquidated damages of $20,000.00 being immediately due and payable to the Buyer, at the Buyer’s
election, in the form of a cash payment.

In
the event of default, the QC Note accrues interest at a rate of 24% per annum or the maximum rate permitted by law, whichever is less.
The QC Note also contains standard adjustments for stock splits, dividends, recapitalizations, and includes anti-dilution protections.

In
connection with the Purchase Agreement, the Company also issued to QC a warrant resulting in the issuance of 2,777,778 warrant shares
at an exercise price of $.02 per share with a 5 year term equivalent to 100% warrant coverage, entitling QC to purchase shares of common
stock equal to 100% of the principal amount of the QC Note. The Company covenants that while the Note and/or Warrant remain outstanding,
the Company will reserve from its authorized and unissued Common Stock, three times (300%) of the number of shares of Common Stock, free
from pre-emptive rights, that would be issuable upon full, unconditioned conversion of the Note and exercise of the Warrant calculated
on the basis of the conversion price and exercise price, respectively, in effect as the Closing Date, which such reserved amounts shall
be increased by the Company from time to time in accordance with its obligations under such Securities. In addition to all other rights
in this Agreement and the Note